Ipilimumab 12-month Intensive Pharmacovigilance Protocol
Clinical trial NCT02050594 · COMPLETED
Trial details
- NCT number
- NCT02050594
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.